Medicare Enrolled

Dr. Shnehal Patel, MD

Neurology · Grove City, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
4191 KELNOR DR STE 200, Grove City, OH 43123
6145335500
In practice since 2010 (16 years)
NPI: 1972820447 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Shnehal Patel is a neurology specialist in Grove City, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 11,644 Medicare services across 301 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $142,166 from 21 pharmaceutical and/or device companies across 281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 5% volume in OH $142,166 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,644
Medicare services
Top 5% in OH for neurology
301
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~728 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
11,170 $5 $13
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
315 $126 $252
New patient office visit, complex (60-74 min) 49 $137 $363
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 43 $58 $108
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
31 $131 $359
Chemical nerve block injection, 1-4 muscles
An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated.
23 $116 $412
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
13 $94 $214
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$142,166
Total received (2018-2024)
Avg $20,309/year across 7 years
Top 8% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
281
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137,794 (96.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,373 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,128
2023
$16,570
2022
$47,496
2021
$30,130
2020
$8,636
2019
$25,704
2018
$1,504

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,541
Amneal Pharmaceuticals LLC
$3,506
MDD US Operations, LLC
$3,080
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$28,565
AbbVie, Inc.
$26,929
AbbVie Inc.
$24,049
MDD US Operations, LLC
$20,055
Kyowa Kirin, Inc.
$15,127
Adamas Pharmaceuticals, Inc.
$7,680
Biohaven Pharmaceutical Holding Company Ltd.
$5,547
Neurocrine Biosciences, Inc.
$5,516
Amneal Pharmaceuticals LLC
$3,506
Medtronic, Inc.
$1,635
Abbott Laboratories
$1,507
BOSTON SCIENTIFIC CORPORATION
$897
US WorldMeds, LLC
$500
Neurocrine BioSciences, Inc.
$225
Allergan, Inc.
$203
Acorda Therapeutics, Inc
$88
InSightec,Inc
$84
BAXTER HEALTHCARE
$14
Boston Scientific Corporation
$13
Teva Pharmaceuticals USA, Inc.
$13
IMPEL PHARMACEUTICALS INC.
$12
Top 3 companies account for 56.0% of all-time payments
Associated products mentioned in payments ›
AJOVY · BOTOX · CREXONT · DUOPA · Duopa · Exablate · FLOSEAL · GENERAL DBS · GOCOVRI · Gocovri · INBRIJA · INFINITY · INGREZZA · NOURIANZ · NURTEC ODT · Nourianz · ONGENTYS · Ongentys · PERCEPT PC BRAINSENSE · QULIPTA · Trudhesa · UBRELVY · VERCISE · VRAYLAR · VYALEV · Vercise
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neurology in OH.

Looking for a neurology specialist in Grove City?
Compare neurologists in the Grove City area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
165
Per 100K population
12.5
County median income
$73,795
Nearest hospital
TWIN VALLEY BEHAVIORAL HEALTHCARE
6.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 5% in OH), with speaking/promotional industry engagement in the top 8% of OH peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Patel performed 11,170 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $142,166 from 21 companies across 281 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other neurologists in Grove City?
Dr. Patel's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →